431 results on '"Kambe, Naotomo"'
Search Results
2. Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis
3. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
4. Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome
5. Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
6. CCL2‒CCR2 Signaling in the Skin Drives Surfactant-Induced Irritant Contact Dermatitis through IL-1β‒Mediated Neutrophil Accumulation
7. A New Era with the Development of Cytokine-Based Therapy for Pruritus
8. Presence of immunoglobulin E‐expressing antibody‐secreting cells in the dermis close to bullous pemphigoid lesions
9. CYP4F22 p.V215D is a novel variant causative for lamellar ichthyosis
10. Neutrophilic epitheliotropism, proposed as an auto‐inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases
11. 粘膜優位型尋常性天疱瘡に対してリツキシマブ投与後に COVID-19 肺炎に罹患した 1 例
12. Expression of precipitating factors of pruritus found in humans in an imiquimod-induced psoriasis mouse model
13. Neutrophilic epitheliotropism, proposed as an auto‐inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
14. A case of post herpes zoster granulomatous dermatitis successfully treated with UVA1 phototherapy
15. TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis
16. Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis
17. CYP4F22 p.V215D is a novel variant causative for lamellar ichthyosis.
18. Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
19. Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
20. Innate Immunity
21. Hydroxychloroquine for the treatment of lupus erythematosus with cutaneous involvement: clinical efficacy and serial analysis of anti-DNA antibody levels
22. A case of Kimura disease with atopic dermatitis successfully treated with baricitinib
23. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
24. Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis
25. Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin
26. Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience
27. ESDR145 - Summary of all cases of Schnitzler syndrome in Japan
28. Ten-year-format diary of fever episodes kept over a five-year period by a patient with familial Mediterranean fever
29. Mastocytosis
30. The role of mast cells in autoinflammation
31. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work
32. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ–dependent inflammatory response in macrophages
33. The Potential Role of Basophils in Urticaria
34. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
35. Protein contact dermatitis induced by cabbage with recurrent symptoms after oral intake
36. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery
37. Panniculitis in dermatomyositis: Two cases with antitranscriptional intermediary factor‐1 antibody as myositis‐specific antibody and review of the literature
38. Additional file 1 of Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
39. Anti-TNF treatment corrects IFN-γ–dependent proinflammatory signatures in Blau syndrome patient–derived macrophages
40. A picture of atopic dermatitis is worth a thousand words
41. The Inflammasome, an Innate Immunity Guardian, Participates in Skin Urticarial Reactions and Contact Hypersensitivity
42. Refractory serum immunoglobulin M elevation during anti‐interleukin (IL)‐1‐ or IL‐6‐targeted treatment in four patients with Schnitzler syndrome
43. ESDR209 - TNF-Targeting Treatment Corrects Proinflammatory Signatures of Autoinflammatory Blau Syndrome
44. Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials
45. Case of respiratory discomfort due to myositis after administration of nivolumab
46. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes
47. Lymphocutaneous Type of Nocardiosis Caused by Nocardia vinacea in a Patient with Polymyositis
48. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients
49. Circulating intermediate monocytes produce TARC in sarcoidosis
50. A case of post herpes zoster granulomatous dermatitis successfully treated with UVA1 phototherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.